Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > Small investors

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Feb 02, 2021 3:41pm

100 Views

Post# 32449471

RE:RE:RE:RE:Small investors

Was looking at sp at 6.25. It looks like the discounted shares are going to be over soon. Below 7 is still a deal imo but very soon ppl has to be higher than pp prices. Real value of the company is another thing imo this should be at 12 to 15 as is not considering future. Jmo

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"